Every week, Benzinga’s Inventory Whisper Index combines proprietary information and sample recognition to disclose 5 shares value taking note of beneath the floor.
Buyers are all the time on the lookout for undervalued, unfollowed, and rising shares. There are numerous strategies out there to particular person merchants, however the problem is usually sifting by means of a wealth of data to find new alternatives and perceive why sure shares are fascinating.
Associated Article: Unique: 12 Most Searched Tickers for December on Benzinga Professional – The place Do Tesla, Micron, and Apple Rank?
Right here is the Benzinga Inventory Whisper Index for the week ending January ninth.
Momentus Inc. (NASDAQ:MNTS): Area shares stay a sizzling matter in early 2026, with Momentus hovering 25% final week. The inventory acquired robust curiosity from Benzinga readers after asserting it had produced a 3D-printed gasoline tank that can be examined in house on a service car. This tank was developed by means of a partnership with Velo3D Inc. Momentus referred to as the gasoline tank a “big achievement” and mentioned additive manufacturing may create new potentialities within the house sector. With stories of SpaceX’s IPO in 2026, traders will doubtless deal with house themes. Momentus is a inventory to look at for additional testing of 3D printed gasoline tanks.
Nu Holdings (NYSE:NU): The Latin American digital banking firm had minimal information movement however robust curiosity this week. The corporate reported quarterly ends in November, with earnings per share and gross sales each exceeding analyst expectations. Analysts raised their worth targets in November and December following quarterly outcomes. Nu Holdings has reported robust development in recent times, increasing from its birthplace in Brazil to Mexico and Colombia. Given the excessive stage of reader curiosity, traders might need to regulate the inventory forward of its quarterly outcomes, scheduled for February twenty fifth.
SoFi Applied sciences (NASDAQ:SOFI): This fintech firm has acquired robust curiosity from our readers with some latest analyst notes that would drive worth motion. Whereas the inventory fell this week, it is nonetheless up greater than 90% over the previous 12 months. Goldman Sachs maintained its “impartial” ranking and lowered its worth goal to $24 from $27. Barclays maintained an equal weight ranking and raised its worth goal to $28 from $23. Financial institution of America reinstated protection of the corporate with an underweight ranking and $20 worth goal. Financial institution of America mentioned M&A may happen within the monetary sector, however issued a warning after its inventory worth soared not too long ago. SoFi is scheduled to launch fourth-quarter monetary outcomes on January thirtieth. Analysts anticipate the corporate to report earnings of 12 cents per share on income of $982.68 million. The corporate beat analyst estimates for each earnings per share and gross sales for the fifth consecutive quarter. Inventory costs proceed to be watched intently forward of the upcoming monetary outcomes report.
Zenas BioPharma Inc (NASDAQ:ZBIO): The clinical-stage biotech inventory is up 98% during the last 12 months, however the inventory has declined over the previous week. The corporate introduced the outcomes of a part 3 trial of obexelimab for the immune system illness IGG4-RD. The outcomes confirmed that obexelimab met its major endpoint, and Zenas BioPharma introduced the outcomes as a win. Buyers and analysts weren’t anticipating an enormous win. Morgan Stanley downgraded the inventory from obese to equal weight and lowered its worth goal from $37 to $19. Zenas expects to submit a biologics license software to the FDA within the second quarter of 2026 and a advertising and marketing authorization software to the European Medicines Company within the second half of 2026. Zenas additionally plans to report additional outcomes for obexelimab in a separate Section 2 examine within the fourth quarter of 2026. Zenas might be a inventory to look at in 2026 as a number of catalysts emerge.
NIO Inc (NYSE:NIO): The electrical car firm has made headlines in latest weeks after reaching the milestone of 1 million car manufacturing at its F2 Neopark manufacturing facility in China and asserting fourth-quarter car numbers. Nio mentioned the corporate is concentrating on annual gross sales development of 40% to 50%. Nio reported report deliveries in December, the fourth quarter, and the complete 12 months. Deliveries totaled 124,807 automobiles within the fourth quarter, a rise of 71.7% 12 months over 12 months. Nio’s full-year deliveries totaled 326,028 automobiles, a rise of 46.9% 12 months over 12 months. Nio inventory might be a inventory to look at given its development in China, as some firms comparable to Tesla wrestle within the area.
Keep tuned for subsequent week’s report. Comply with Benzinga Professional for the most recent headlines and high tales shifting the market, proper right here.
Learn the most recent Inventory Whisper Index report right here:
